SecBot SecBot
SECBOTREPLAY Home › Report › MLYS

MLYS · Two insiders at Mineralys Therapeutics (MLYS) sold a combined $310K in…

Mineralys Therapeutics, Inc. · CLUSTER filed Jun 17, 2026 at 21:18 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 17, 2026 at 21:18 ET

Two insiders at Mineralys Therapeutics (MLYS) sold a combined $310K in open-market transactions over a 7-day window. The dollar amount is trivial relative to the $2.0B market cap (0.0155%), and the sales follow option exercises, indicating routine tax/vesting-related liquidity rather than a bearish signal.

  • CMO Rodman David Malcom sold 9,900 shares at $23.81 on June 15, 2026, for $235K
  • Director Daphne Karydas sold 3,000 shares at $25.00 on June 17, 2026, for $75K
  • Total open-market sales of $310K represent 0.0155% of MLYS's $2.0B market cap
  • Both sales were preceded by option exercises at nominal or low strike prices, consistent with tax withholding or diversification

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access